For more than 50 years, we have delivered expert API (application programming interface) development and manufacturing solutions to our customers in a highly differentiated outsourced experience that places equal emphasis on true partnership and scientific excellence.
Our customers benefit from our passionate team, our full-lifecycle capabilities, and our unwavering commitment to treating our customers’ molecules as our own.
As a small molecule PDMO (partnership development and manufacturing organisation), Sterling Pharma Solutions delivers comprehensive small molecule services spanning pre-clinical development to full commercial manufacturing.
Widely recognised for our collaborative and transparent team, our expertise in complex and hazardous chemistries, and our service-focused customer experience, Sterling is a proven and trusted partner to the world’s most innovative biotechs and leading pharmaceutical companies.
We believe that whilst science can be complex, partnerships should be simple. We provide our customers a simple, collaborative way of working marked by transparency and trust.
At Sterling, we pride ourselves on being easy to do business with, and we are focused on upholding a simple and collaborative way of working. We are so much more than a traditional CDMO (contract development and manufacturing organisation). We are a PDMO.
Differentiated by the three core characteristics of service, passion, and science, we put our customers’ products first to transform the outsourcing experience.
Located at centres of pharmaceutical innovation in the UK and US, our facilities are purpose-built to handle your needs from discovery through full commercialisation.
With state-of-the-art-equipment and accreditation for cGMP manufacturing, our various sites enable us to flexibly support a broad range of project requirements while ensuring safety, quality, and compliance.
